PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
14 sept. 2023 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Brain Implants Market to hit USD 10 billion by 2032, says Global Market Insights Inc.
10 sept. 2023 19h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Sept. 10, 2023 (GLOBE NEWSWIRE) -- Brain Implants Market size is expected to be worth USD 10 billion by 2032. The growing burden of neurological disorders along with the...
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
13 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
Synapse Dental Pain Eraser Receives 2023 Cellerant Best of Class Hygiene Award for Setting a New Standard of Patient Care in Dentistry
12 juil. 2023 09h00 HE
|
Synapse Dental
CRANSTON, R.I., July 12, 2023 (GLOBE NEWSWIRE) -- The Synapse Dental Pain Eraser – the world’s first pen-shaped, portable, electronic dental anesthesia solution to prevent and relieve oral pain...
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
07 juil. 2023 07h09 HE
|
Magstim EGI
WHITLAND, United Kingdom, July 07, 2023 (GLOBE NEWSWIRE) -- The advanced and FDA-cleared Magstim Horizon 3.0 transcranial magnetic stimulation (TMS) system is now UKCA registered and available for...
Global Nerve Repair and Regeneration Devices Strategic Business Report 2023: Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
21 juin 2023 04h23 HE
|
Research and Markets
Dublin, June 21, 2023 (GLOBE NEWSWIRE) -- The "Nerve Repair and Regeneration Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Independent clinical study shows Curonix’s Freedom® PNS System significantly reduces pain scores and medication usage
07 juin 2023 07h00 HE
|
Curonix LLC
POMPANO BEACH, Fla., June 07, 2023 (GLOBE NEWSWIRE) -- Curonix LLC, a medical technology company dedicated to freeing patients from chronic pain, announced the publication of 24 months of data from...
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
05 juin 2023 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Global Nerve Repair and Regeneration Market is expected to grow at a lucrative rate of ~12% by 2027 : Growing Cases of Nerve Injuries
26 avr. 2023 12h20 HE
|
Medi-Tech Insights
BRUSSELS, BELGIUM, April 26, 2023 (GLOBE NEWSWIRE) -- Repair and regeneration in the nervous system is a process by which damaged tissue undergoes regrowth or renewal, eventually restoring nervous...
Global Neuromodulation Devices Markets, 2022-2029: Growing Prevalence of Central Nervous System Disorders Such as Parkinson Disease, Alzheimer Disease, Multiple Sclerosis, Epilepsy Bolsters Growth
19 avr. 2023 04h53 HE
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Neuromodulation Devices Global Market- Forecast To 2029" report has been added to ResearchAndMarkets.com's offering. The neuromodulation devices...